Showing results (141-150 of 219) with videos related to

Sort By:
Pageof 22
Thescientificworldjournal|December 24, 2013
A real-world, multicenter assessment of drugs requiring weight-based calculations in overweight, adult critically ill patientsSandra L Kane-Gill, Nicholas P Wytiaz, Lisa M Thompson, et al.
Clinical Pharmacology and Therapeutics|December 21, 2025
Risk of Acute Kidney Injury Associated With Nephrotoxic Burden in Hospitalized Patients: A Scoping ReviewWafa Alatawi, Jessica L Wallace, Dhakrit Rungkitwattanakul, et al.
Journal of Biomedical Informatics|March 18, 2023
Developing a Knowledge Graph for Pharmacokinetic Natural Product-Drug InteractionsSanya B Taneja, Tiffany J Callahan, Mary F Paine, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 23, 2024
Protective effects of silymarin on preventing vancomycin nephrotoxicity in infectious patients: a randomized, double-blinded, placebo-controlled, pilot clinical trialAva Karimian, Iman Karimzadeh, Mojtaba Shafiekhani, et al.
Journal of Intensive Care Medicine|August 27, 2020
Sedation, Analgesia, and Paralysis in COVID-19 Patients in the Setting of Drug ShortagesMahmoud A Ammar, Gretchen L Sacha, Sarah C Welch, et al.
Journal of the American Medical Directors Association|May 13, 2014
Determining the incidence of drug-associated acute kidney injury in nursing home residentsSteven M Handler, Pui Wen Cheung, Colleen M Culley, et al.
Critical Care Medicine|April 10, 2015
A Multicenter Evaluation of Off-Label Medication Use and Associated Adverse Drug Reactions in Adult Medical ICUsPamela L Smithburger, Mitchell S Buckley, Mark A Culver, et al.
Surgery|June 14, 2023
A deep learning-based dynamic model for predicting acute kidney injury risk severity in postoperative patientsEsra Adiyeke, Yuanfang Ren, Matthew M Ruppert, et al.
Pharmacology Research & Perspectives|December 25, 2024
Part 1: Evaluation of Pediatric Cannabis-Drug Interaction ReportsMaryann R Chapin, Sandra L Kane-Gill, Xiaotong Li, et al.
Pageof 22